Integral Investment Advisors, Inc.
Source: SEC Form 13F · as of Mar 2026Integral Investment Advisors, Inc. holds 13 biotech & pharma companies tracked by BioSniper, totaling $11.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$11.3M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 4,551 | $4.2M |
| JNJJOHNSON & JOHNSON | 16,567 | $4.0M |
| GILDGILEAD SCIENCES, INC. | 4,577 | $638K |
| ZTSZoetis Inc. | 3,090 | $365K |
| AMGNAMGEN INC | 931 | $328K |
| PMPhilip Morris International Inc | 1,950 | $322K |
| ABBVAbbVie Inc. | 1,454 | $316K |
| ABTABBOTT LABORATORIES | 2,935 | $301K |
| PFEPFIZER INC | 9,713 | $273K |
| MRKMerck & Co., Inc. | 2,230 | $268K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 754 | $204K |
| RXRXRECURSION PHARMACEUTICALS, INC. | 12,850 | $39K |
| MISTMilestone Pharmaceuticals Inc. | 10,000 | $12K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.